ESR1 and neoplasm: In spite of totally down-regulation of NNT-AS1 in tumortissues compared to ANCTs, we demonstrated higherexpression of it in ER negative tumor samples, comparedto ER positive samples, likely suggesting the importanceof this lncRNA in pathogenesis of ER negative breastcancers.